Torrent Pharma Received a Clean USFDA Outcome & Strategic Control at 48.75% in JB Chemicals

has achieved a clean outcome from the US Food and Drug Administration (USFDA) inspection at its Dahej manufacturing facility, with zero observations reported after a thorough audit from January 19–23, 2026, demonstrating robust compliance with global quality and manufacturing standards. At the same time, Torrent has expanded its ownership in J.B. Chemicals & Pharmaceuticals, acquiring an additional 2.36% stake and taking its total holding to 48.75% on a fully diluted basis, strengthening its control and strategic footprint in the chronic therapy and generics space. This combination of regulatory validation and increased stake reflects operational discipline and proactive portfolio consolidation in India’s competitive pharmaceutical sector. Disclaimer: This post is for informational purposes only and not a recommendation to buy or sell any securities. I, or my family, associates, or relatives, may have a financial interest in the securities mentioned.